4-demethoxydaunorubicin ( nsc-256439 ) was effective against l1210 and gross leukemias and ascites and solid sarcoma 180 at doses four to eight times lower than those effective for daunorubicin .
C0020789
4-demethoxydaunorubicin
C0011015
daunorubicin